Felicitex Therapeutics Inc. S-1
Accession 0001213900-22-046405
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:58 PM ET
Size
77.7 MB
Accession
0001213900-22-046405
Documents
- S-1ea164009-s1_felicitex.htmPrimary
REGISTRATION STATEMENT
- EX-3.1ea164009ex3-1_felicitex.htm
CERTIFICATE OF INCORPORATION OF FELICITEX THERAPEUTICS INC
- EX-3.2ea164009ex3-2_felicitex.htm
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF FELICITEX THERAPEUTICS INC
- EX-3.3ea164009ex3-3_felicitex.htm
SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF FELICITEX THERAPEUTICS INC
- EX-3.4ea164009ex3-4_felicitex.htm
CERTIFICATE OF AMENDMENT OF FELICITEX THERAPEUTICS INC
- EX-3.5ea164009ex3-5_felicitex.htm
SECOND CERTIFICATE OF AMENDMENT OF FELICITEX THERAPEUTICS INC
- EX-3.6ea164009ex3-6_felicitex.htm
THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF FELICITEX THERAPEUTICS INC
- EX-3.8ea164009ex3-8_felicitex.htm
BYLAWS OF FELICITEX THERAPEUTICS INC
- EX-3.9ea164009ex3-9_felicitex.htm
CERTIFICATE OF MERGER OF TARMETA BIOSCIENCES, LLC AND FELICITEX THERAPEUTICS INC., DATED DECEMBER 30, 2021
- EX-4.5ea164009ex4-5_felicitex.htm
WARRANT TO PURCHASE COMMON SHARES BETWEEN FELICITEX THERAPEUTICS INC. AND MARC DUEY, DATED MARCH 17, 2020
- EX-4.6ea164009ex4-6_felicitex.htm
WARRANT TO PURCHASE COMMON SHARES BETWEEN FELICITEX THERAPEUTICS INC. AND MARC DUEY, DATED MARCH 17, 2021
- EX-4.7ea164009ex4-7_felicitex.htm
WARRANT TO PURCHASE COMMON SHARES BETWEEN FELICITEX THERAPEUTICS, INC AND MARC DUEY, DATED NOVEMBER 2, 2021
- EX-10.1ea164009ex10-1_felicitex.htm
AGREEMENT AND PLAN OF MERGER BETWEEN FELICITEX THERAPEUTICS INC. AND TARMETA BIOSCIENCES, LLC, DATED DECEMBER 30, 2021
- EX-10.2ea164009ex10-2_felicitex.htm
LICENSE AND COLLABORATION AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND DIAXONHIT, DATED APRIL 16, 2014
- EX-10.3ea164009ex10-3_felicitex.htm
AMENDMENT NO. 1 TO LICENSE AND COLLABORATION AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND DIAXONHIT, DATED JULY 21, 2014
- EX-10.4ea164009ex10-4_felicitex.htm
AMENDMENT NO. 2 TO LICENSE AND COLLABORATION AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND EUROBIO SCIENTIFIC SA (FORMERLY DIAXONHIT), DATED FEBRUARY 14, 2022
- EX-10.5ea164009ex10-5_felicitex.htm
RESEARCH COLLABORATION AND LICENSING OPTION AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND SELVITA S.A., DATED NOVEMBER 6, 2014
- EX-10.6ea164009ex10-6_felicitex.htm
NOTICE OF OPTION EXERCISE UNDER THE RESEARCH COLLABORATION AND OPTION AGREEMENT DATED OCTOBER 1, 2014, DATED AUGUST 30, 2018
- EX-10.7ea164009ex10-7_felicitex.htm
EXCLUSIVE LICENSE AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND SELVITA S.A., DATED DECEMBER 31, 2018
- EX-10.8ea164009ex10-8_felicitex.htm
AMENDMENT NO. 1 TO EXCLUSIVE LICENSING AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND SELVITA S.A., DATED APRIL 16, 2019
- EX-10.9ea164009ex10-9_felicitex.htm
MATERIAL TRANSFER AND ROYALTY AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND MEMORIAL SLOAN KETTERING CANCER CENTER, DATED DECEMBER 4, 2020
- EX-10.10ea164009ex10-10_felicitex.htm
MATERIAL TRANSFER AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND EQUILIBRE BIOPHARMACEUTICALS, DATED FEBRUARY 15, 2021
- EX-10.11ea164009ex10-11_felicitex.htm
MATERIAL TRANSFER AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH, DATED JANUARY 29, 2020
- EX-10.12ea164009ex10-12_felicitex.htm
EMPLOYMENT AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND MARIA VILENCHIK DATED MARCH 10, 2022
- EX-10.13ea164009ex10-13_felicitex.htm
EMPLOYMENT CONTRACT BETWEEN FELICITEX THERAPEUTICS AND ALEXEI BELENKY DATED DECEMBER 30, 2021
- EX-10.14ea164009ex10-14_felicitex.htm
FORM OF INDEPENDENT DIRECTOR AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND EACH INDEPENDENT DIRECTOR AND EACH DIRECTOR NOMINEE
- EX-10.15ea164009ex10-15_felicitex.htm
FORM OF INDEMNIFICATION AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND EACH INDEPENDENT DIRECTOR AND EACH DIRECTOR NOMINEE
- EX-10.16ea164009ex10-16_felicitex.htm
FELICITEX THERAPEUTICS INC. 2012 STOCK OPTION AND RESTRICTED STOCK PLAN
- EX-10.17ea164009ex10-17_felicitex.htm
FELICITEX THERAPEUTICS NON-STATUTORY STOCK OPTION AGREEMENT WITH VALERIA POVOLOTSKY, DATED MARCH 1, 2013
- EX-10.18ea164009ex10-18_felicitex.htm
FELICITEX THERAPEUTICS NON-STATUTORY STOCK OPTION AGREEMENT WITH YURIY GANKIN DATED MARCH 1, 2013
- EX-10.19ea164009ex10-19_felicitex.htm
FELICITEX THERAPEUTICS NON-STATUTORY STOCK OPTION AGREEMENT WITH MICHAEL FRID DATED MARCH 1, 2013
- EX-10.20ea164009ex10-20_felicitex.htm
FELICITEX THERAPEUTICS NON-STATUTORY STOCK OPTION AGREEMENT WITH MARIA VILENCHIK DATED MARCH 1, 2013
- EX-10.21ea164009ex10-21_felicitex.htm
FELICITEX THERAPEUTICS INC. 2022 EQUITY INCENTIVE PLAN
- EX-10.22ea164009ex10-22_felicitex.htm
SHAREHOLDER LOAN AGREEMENT BETWEEN MARC DUEY AND FELICITEX THERAPEUTICS INC., DATED JANUARY 16, 2018
- EX-10.23ea164009ex10-23_felicitex.htm
SHAREHOLDER LOAN AGREEMENT BETWEEN MARC DUEY AND FELICITEX THERAPEUTICS INC., DATED MARCH 31, 2020
- EX-10.24ea164009ex10-24_felicitex.htm
GRID NOTE BETWEEN MARC DUEY AND FELICITEX THERAPEUTICS DATED MARCH 16, 2022
- EX-10.25ea164009ex10-25_felicitex.htm
GRANT AGREEMENT FROM MASSACHUSETTS LIFE SCIENCES CENTER DATED JULY 15, 2015
- EX-10.26ea164009ex10-26_felicitex.htm
CONSULTING AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND MICHAEL FRID, DATED JULY 20, 2012
- EX-10.27ea164009ex10-27_felicitex.htm
CONSULTING AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND VALERIA POVOLOTSKY, PH.D., DATED JULY 20, 2012
- EX-10.28ea164009ex10-28_felicitex.htm
LEASE BETWEEN FELICITEX THERAPEUTICS INC., TARMETA BIOSCIENCES, LLC AND KAUFMAN NIR LLC, DATED MARCH 15, 2017
- EX-10.30ea164009ex10-30_felicitex.htm
BOARD OF DIRECTORS AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND YURIY GANKIN, DATED JULY 23, 2021
- EX-10.31ea164009ex10-31_felicitex.htm
BOARD OF DIRECTORS AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND VALERIA POVOLOTSKY, DATED JULY 23, 2021
- EX-10.32ea164009ex10-32_felicitex.htm
BOARD OF DIRECTORS AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND MICHAEL FRID, DATED JULY 23, 2021
- EX-10.33ea164009ex10-33_felicitex.htm
BOARD OF DIRECTORS AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND ALEX SHLYANKEVICH, DATED JULY 23, 2021
- EX-10.34ea164009ex10-34_felicitex.htm
BOARD OF DIRECTORS AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND MARC DUEY, DATED JULY 23, 2021
- EX-10.35ea164009ex10-35_felicitex.htm
BOARD OF DIRECTORS AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND MARIA VILENCHIK, DATED JULY 23, 2021
- EX-10.36ea164009ex10-36_felicitex.htm
MATERIAL TRANSFER AND AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND UAB DOLCERX BALTIKA, DATED MAY 15, 2021
- EX-10.37ea164009ex10-37_felicitex.htm
MATERIAL TRANSFER AND AGREEMENT BETWEEN FELICITEX THERAPEUTICS INC. AND BARBARA ANN KARMANOS CANCER INSTITUTE, DATED JULY 18, 2022
- EX-14.1ea164009ex14-1_felicitex.htm
CODE OF ETHICS AND BUSINESS CONDUCT
- EX-21.1ea164009ex21-1_felicitex.htm
LIST OF SUBSIDIARIES
- EX-23.1ea164009ex23-1_felicitex.htm
CONSENT OF FRIEDMAN LLP
- EX-99.1ea164009ex99-1_felicitex.htm
AUDIT COMMITTEE CHARTER
- EX-99.2ea164009ex99-2_felicitex.htm
COMPENSATION COMMITTEE CHARTER
- EX-99.3ea164009ex99-3_felicitex.htm
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER
- EX-99.5ea164009ex99-5_felicitex.htm
CONSENT OF DOUGLAS T. MOORE TO BE NAMED AS A DIRECTOR NOMINEE
- EX-FILINGea164009ex-fee_felicitex.htm
FILING FEES TABLE
- GRAPHICimage_001.jpg
GRAPHIC
- GRAPHICimage_002.jpg
GRAPHIC
- GRAPHICimage_003.jpg
GRAPHIC
- GRAPHICimage_004.jpg
GRAPHIC
- GRAPHICimage_005.jpg
GRAPHIC
- GRAPHICimage_006.jpg
GRAPHIC
- GRAPHICimage_007.jpg
GRAPHIC
- GRAPHICimage_008.jpg
GRAPHIC
- GRAPHICimage_009.jpg
GRAPHIC
- GRAPHICimage_010.jpg
GRAPHIC
- GRAPHICimage_011.jpg
GRAPHIC
- GRAPHICimage_012.jpg
GRAPHIC
- GRAPHICimage_013.jpg
GRAPHIC
- GRAPHICex3-1_001.jpg
GRAPHIC
- GRAPHICex3-2_001.jpg
GRAPHIC
- GRAPHICex3-2_002.jpg
GRAPHIC
- GRAPHICex3-2_003.jpg
GRAPHIC
- GRAPHICex3-2_004.jpg
GRAPHIC
- GRAPHICex3-2_005.jpg
GRAPHIC
- GRAPHICex3-3_001.jpg
GRAPHIC
- GRAPHICex3-3_002.jpg
GRAPHIC
- GRAPHICex3-3_003.jpg
GRAPHIC
- GRAPHICex3-3_004.jpg
GRAPHIC
- GRAPHICex3-3_005.jpg
GRAPHIC
- GRAPHICex3-3_006.jpg
GRAPHIC
- GRAPHICex3-3_007.jpg
GRAPHIC
- GRAPHICex3-3_008.jpg
GRAPHIC
- GRAPHICex3-3_009.jpg
GRAPHIC
- GRAPHICex3-3_010.jpg
GRAPHIC
- GRAPHICex3-3_011.jpg
GRAPHIC
- GRAPHICex3-3_012.jpg
GRAPHIC
- GRAPHICex3-3_013.jpg
GRAPHIC
- GRAPHICex3-3_014.jpg
GRAPHIC
- GRAPHICex3-3_015.jpg
GRAPHIC
- GRAPHICex3-3_016.jpg
GRAPHIC
- GRAPHICex3-3_017.jpg
GRAPHIC
- GRAPHICex3-3_018.jpg
GRAPHIC
- GRAPHICex3-3_019.jpg
GRAPHIC
- GRAPHICex3-3_020.jpg
GRAPHIC
- GRAPHICex3-3_021.jpg
GRAPHIC
- GRAPHICex3-3_022.jpg
GRAPHIC
- GRAPHICex3-3_023.jpg
GRAPHIC
- GRAPHICex3-3_024.jpg
GRAPHIC
- GRAPHICex3-4_001.jpg
GRAPHIC
- GRAPHICex3-4_002.jpg
GRAPHIC
- GRAPHICex3-4_003.jpg
GRAPHIC
- GRAPHICex3-5_001.jpg
GRAPHIC
- GRAPHICex3-5_002.jpg
GRAPHIC
- GRAPHICex3-6_001.jpg
GRAPHIC
- GRAPHICex3-6_002.jpg
GRAPHIC
- GRAPHICex3-6_003.jpg
GRAPHIC
- GRAPHICex3-6_004.jpg
GRAPHIC
- GRAPHICex3-6_005.jpg
GRAPHIC
- GRAPHICex3-9_001.jpg
GRAPHIC
- GRAPHICex3-9_002.jpg
GRAPHIC
- GRAPHICex3-9_003.jpg
GRAPHIC
- GRAPHICex10-2_001.jpg
GRAPHIC
- GRAPHICex10-2_002.jpg
GRAPHIC
- GRAPHICex10-2_003.jpg
GRAPHIC
- GRAPHICex10-2_004.jpg
GRAPHIC
- GRAPHICex10-2_005.jpg
GRAPHIC
- GRAPHICex10-2_006.jpg
GRAPHIC
- GRAPHICex10-2_007.jpg
GRAPHIC
- GRAPHICex10-2_008.jpg
GRAPHIC
- GRAPHICex10-2_009.jpg
GRAPHIC
- GRAPHICex10-2_010.jpg
GRAPHIC
- GRAPHICex10-2_011.jpg
GRAPHIC
- GRAPHICex10-2_012.jpg
GRAPHIC
- GRAPHICex10-2_013.jpg
GRAPHIC
- GRAPHICex10-2_014.jpg
GRAPHIC
- GRAPHICex10-2_015.jpg
GRAPHIC
- GRAPHICex10-2_016.jpg
GRAPHIC
- GRAPHICex10-2_017.jpg
GRAPHIC
- GRAPHICex10-2_018.jpg
GRAPHIC
- GRAPHICex10-2_019.jpg
GRAPHIC
- GRAPHICex10-2_020.jpg
GRAPHIC
- GRAPHICex10-2_021.jpg
GRAPHIC
- GRAPHICex10-3_001.jpg
GRAPHIC
- GRAPHICex10-3_002.jpg
GRAPHIC
- GRAPHICex10-4_001.jpg
GRAPHIC
- GRAPHICex10-4_002.jpg
GRAPHIC
- GRAPHICex10-4_003.jpg
GRAPHIC
- GRAPHICex10-5_001.jpg
GRAPHIC
- GRAPHICex10-5_002.jpg
GRAPHIC
- GRAPHICex10-5_003.jpg
GRAPHIC
- GRAPHICex10-5_004.jpg
GRAPHIC
- GRAPHICex10-5_005.jpg
GRAPHIC
- GRAPHICex10-5_006.jpg
GRAPHIC
- GRAPHICex10-5_007.jpg
GRAPHIC
- GRAPHICex10-5_008.jpg
GRAPHIC
- GRAPHICex10-5_009.jpg
GRAPHIC
- GRAPHICex10-5_010.jpg
GRAPHIC
- GRAPHICex10-5_011.jpg
GRAPHIC
- GRAPHICex10-5_012.jpg
GRAPHIC
- GRAPHICex10-5_013.jpg
GRAPHIC
- GRAPHICex10-5_014.jpg
GRAPHIC
- GRAPHICex10-5_015.jpg
GRAPHIC
- GRAPHICex10-5_016.jpg
GRAPHIC
- GRAPHICex10-6_001.jpg
GRAPHIC
- GRAPHICex10-6_002.jpg
GRAPHIC
- GRAPHICex10-6_003.jpg
GRAPHIC
- GRAPHICex10-6_004.jpg
GRAPHIC
- GRAPHICex10-6_005.jpg
GRAPHIC
- GRAPHICex10-6_006.jpg
GRAPHIC
- GRAPHICex10-6_007.jpg
GRAPHIC
- GRAPHICex10-6_008.jpg
GRAPHIC
- GRAPHICex10-6_009.jpg
GRAPHIC
- GRAPHICex10-7_001.jpg
GRAPHIC
- GRAPHICex10-7_002.jpg
GRAPHIC
- GRAPHICex10-7_003.jpg
GRAPHIC
- GRAPHICex10-7_004.jpg
GRAPHIC
- GRAPHICex10-7_005.jpg
GRAPHIC
- GRAPHICex10-7_006.jpg
GRAPHIC
- GRAPHICex10-7_007.jpg
GRAPHIC
- GRAPHICex10-7_008.jpg
GRAPHIC
- GRAPHICex10-7_009.jpg
GRAPHIC
- GRAPHICex10-7_010.jpg
GRAPHIC
- GRAPHICex10-7_011.jpg
GRAPHIC
- GRAPHICex10-8_001.jpg
GRAPHIC
- GRAPHICex10-8_002.jpg
GRAPHIC
- GRAPHICex10-11_001.jpg
GRAPHIC
- GRAPHICex10-11_002.jpg
GRAPHIC
- GRAPHICex10-11_003.jpg
GRAPHIC
- GRAPHICex10-11_004.jpg
GRAPHIC
- GRAPHICex10-11_005.jpg
GRAPHIC
- GRAPHICex10-11_006.jpg
GRAPHIC
- GRAPHICex10-11_007.jpg
GRAPHIC
- GRAPHICex10-11_008.jpg
GRAPHIC
- GRAPHICex10-11_009.jpg
GRAPHIC
- GRAPHICex10-11_010.jpg
GRAPHIC
- GRAPHICex10-11_011.jpg
GRAPHIC
- GRAPHICex10-12_001.jpg
GRAPHIC
- GRAPHICex10-16_001.jpg
GRAPHIC
- GRAPHICex10-16_002.jpg
GRAPHIC
- GRAPHICex10-16_003.jpg
GRAPHIC
- GRAPHICex10-16_004.jpg
GRAPHIC
- GRAPHICex10-16_005.jpg
GRAPHIC
- GRAPHICex10-16_006.jpg
GRAPHIC
- GRAPHICex10-16_007.jpg
GRAPHIC
- GRAPHICex10-16_008.jpg
GRAPHIC
- GRAPHICex10-16_009.jpg
GRAPHIC
- GRAPHICex10-16_010.jpg
GRAPHIC
- GRAPHICex10-17_001.jpg
GRAPHIC
- GRAPHICex10-17_002.jpg
GRAPHIC
- GRAPHICex10-17_003.jpg
GRAPHIC
- GRAPHICex10-17_004.jpg
GRAPHIC
- GRAPHICex10-17_005.jpg
GRAPHIC
- GRAPHICex10-17_006.jpg
GRAPHIC
- GRAPHICex10-17_007.jpg
GRAPHIC
- GRAPHICex10-17_008.jpg
GRAPHIC
- GRAPHICex10-19_001.jpg
GRAPHIC
- GRAPHICex10-19_002.jpg
GRAPHIC
- GRAPHICex10-19_003.jpg
GRAPHIC
- GRAPHICex10-19_004.jpg
GRAPHIC
- GRAPHICex10-19_005.jpg
GRAPHIC
- GRAPHICex10-19_006.jpg
GRAPHIC
- GRAPHICex10-19_007.jpg
GRAPHIC
- GRAPHICex10-19_008.jpg
GRAPHIC
- GRAPHICex10-20_001.jpg
GRAPHIC
- GRAPHICex10-20_002.jpg
GRAPHIC
- GRAPHICex10-20_003.jpg
GRAPHIC
- GRAPHICex10-20_004.jpg
GRAPHIC
- GRAPHICex10-20_005.jpg
GRAPHIC
- GRAPHICex10-20_006.jpg
GRAPHIC
- GRAPHICex10-20_007.jpg
GRAPHIC
- GRAPHICex10-20_008.jpg
GRAPHIC
- GRAPHICex10-25_001.jpg
GRAPHIC
- GRAPHICex10-25_002.jpg
GRAPHIC
- GRAPHICex10-25_003.jpg
GRAPHIC
- GRAPHICex10-25_004.jpg
GRAPHIC
- GRAPHICex10-25_005.jpg
GRAPHIC
- GRAPHICex10-25_006.jpg
GRAPHIC
- GRAPHICex10-25_007.jpg
GRAPHIC
- GRAPHICex10-25_008.jpg
GRAPHIC
- GRAPHICex10-25_009.jpg
GRAPHIC
- GRAPHICex10-25_010.jpg
GRAPHIC
- GRAPHICex10-25_011.jpg
GRAPHIC
- GRAPHICex10-25_012.jpg
GRAPHIC
- GRAPHICex10-25_013.jpg
GRAPHIC
- GRAPHICex10-25_014.jpg
GRAPHIC
- GRAPHICex10-25_015.jpg
GRAPHIC
- GRAPHICex10-25_016.jpg
GRAPHIC
- GRAPHICex10-25_017.jpg
GRAPHIC
- GRAPHICex10-25_018.jpg
GRAPHIC
- GRAPHICex10-25_019.jpg
GRAPHIC
- GRAPHICex10-25_020.jpg
GRAPHIC
- GRAPHICex10-25_021.jpg
GRAPHIC
- GRAPHICex10-25_022.jpg
GRAPHIC
- GRAPHICex10-25_023.jpg
GRAPHIC
- GRAPHICex10-25_024.jpg
GRAPHIC
- GRAPHICex10-25_025.jpg
GRAPHIC
- GRAPHICex10-25_026.jpg
GRAPHIC
- GRAPHICex10-25_027.jpg
GRAPHIC
- GRAPHICex10-25_028.jpg
GRAPHIC
- GRAPHICex10-25_029.jpg
GRAPHIC
- GRAPHICex10-25_030.jpg
GRAPHIC
- GRAPHICex10-25_031.jpg
GRAPHIC
- GRAPHICex10-25_032.jpg
GRAPHIC
- GRAPHICex10-25_033.jpg
GRAPHIC
- GRAPHICex10-25_034.jpg
GRAPHIC
- GRAPHICex10-25_035.jpg
GRAPHIC
- GRAPHICex10-25_036.jpg
GRAPHIC
- GRAPHICex10-25_037.jpg
GRAPHIC
- GRAPHICex10-25_038.jpg
GRAPHIC
- GRAPHICex10-25_039.jpg
GRAPHIC
- GRAPHICex10-25_040.jpg
GRAPHIC
- GRAPHICex10-25_041.jpg
GRAPHIC
- GRAPHICex10-25_042.jpg
GRAPHIC
- GRAPHICex10-25_043.jpg
GRAPHIC
- GRAPHICex10-25_044.jpg
GRAPHIC
- GRAPHICex10-25_045.jpg
GRAPHIC
- GRAPHICex10-25_046.jpg
GRAPHIC
- GRAPHICex10-25_047.jpg
GRAPHIC
- GRAPHICex10-25_048.jpg
GRAPHIC
- GRAPHICex10-25_049.jpg
GRAPHIC
- GRAPHICex10-25_050.jpg
GRAPHIC
- GRAPHICex10-25_051.jpg
GRAPHIC
- GRAPHICex10-25_052.jpg
GRAPHIC
- GRAPHICex10-25_053.jpg
GRAPHIC
- GRAPHICex10-25_054.jpg
GRAPHIC
- GRAPHICex10-25_055.jpg
GRAPHIC
- GRAPHICex10-25_056.jpg
GRAPHIC
- GRAPHICex10-25_057.jpg
GRAPHIC
- GRAPHICex10-27_001.jpg
GRAPHIC
- GRAPHICex10-27_002.jpg
GRAPHIC
- GRAPHICex10-27_003.jpg
GRAPHIC
- GRAPHICex10-27_004.jpg
GRAPHIC
- GRAPHICex10-27_005.jpg
GRAPHIC
- GRAPHICex10-27_006.jpg
GRAPHIC
- GRAPHICex10-27_007.jpg
GRAPHIC
- GRAPHICex10-27_008.jpg
GRAPHIC
- GRAPHICex10-27_009.jpg
GRAPHIC
- GRAPHICex10-27_010.jpg
GRAPHIC
- GRAPHICex10-27_011.jpg
GRAPHIC
- GRAPHICex10-27_012.jpg
GRAPHIC
- GRAPHICex10-27_013.jpg
GRAPHIC
- GRAPHICex10-27_014.jpg
GRAPHIC
- GRAPHICex10-28_001.jpg
GRAPHIC
- GRAPHICex10-28_002.jpg
GRAPHIC
- GRAPHICex10-28_003.jpg
GRAPHIC
- GRAPHICex10-28_004.jpg
GRAPHIC
- GRAPHICex10-28_005.jpg
GRAPHIC
- GRAPHICex10-28_006.jpg
GRAPHIC
- GRAPHICex10-28_007.jpg
GRAPHIC
- GRAPHICex10-28_008.jpg
GRAPHIC
- GRAPHICex10-28_009.jpg
GRAPHIC
Issuer
Felicitex Therapeutics Inc.
CIK 0001912287
Related Parties
1- filerCIK 0001912287
Filing Metadata
- Form type
- S-1
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:58 PM ET
- Size
- 77.7 MB